MOACM
RPRX

Mutual of America Capital Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Mutual of America Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-34,701
Closed -$344K – 1289
2014
Q3 		$344K Hold
34,701
– – 0.01% 1143
2014
Q2 		$600K Buy
34,701
+9,801
+39% +$160K 0.01% 1104
2014
Q1 		$442K Buy
+24,900
New +$482K 0.01% 1128

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mutual of America Capital Management's RPRX Position: Q4 2014 in Review

Mutual of America Capital Management sold out of Repros Therapeutics Inc. (RPRX) in Q4 2014, closing a stake of 34,701 shares — an estimated $344K sold.

Mutual of America Capital Management first reported a position in RPRX in Q1 2014 and held it in 3 quarters. The position peaked at $600K in Q2 2014. 80 funds tracked by Wall St. Rank hold RPRX as of Q4 2014.

  • Mutual of America Capital Management reported no remaining Repros Therapeutics Inc. position as of Q4 2014 after selling out during the quarter.
  • Mutual of America Capital Management sold 34,701 Repros Therapeutics Inc. shares in Q4 2014, an estimated $344K.
  • Mutual of America Capital Management first reported a position in Repros Therapeutics Inc. in Q1 2014 and held it in 3 quarters.
  • Mutual of America Capital Management's Repros Therapeutics Inc. position peaked at $600K in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2014.

Based on Mutual of America Capital Management's 13F filing for Q4 2014, filed 4 Feb 2015.